ANIP logo

ANI Pharmaceuticals (ANIP) EBITDA

annual EBITDA:

$63.12M-$43.48M(-40.79%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual EBITDA is $63.12 million, with the most recent change of -$43.48 million (-40.79%) on December 31, 2024.
  • During the last 3 years, ANIP annual EBITDA has risen by +$60.01 million (+1925.71%).
  • ANIP annual EBITDA is now -40.79% below its all-time high of $106.60 million, reached on December 31, 2023.

Performance

ANIP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

quarterly EBITDA:

$48.36M+$33.51M(+225.60%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly EBITDA is $48.36 million, with the most recent change of +$33.51 million (+225.60%) on March 31, 2025.
  • Over the past year, ANIP quarterly EBITDA has increased by +$3.74 million (+8.38%).
  • ANIP quarterly EBITDA is now at all-time high.

Performance

ANIP quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

TTM EBITDA:

$66.86M+$3.74M(+5.93%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM EBITDA is $66.86 million, with the most recent change of +$3.74 million (+5.93%) on March 31, 2025.
  • Over the past year, ANIP TTM EBITDA has dropped by -$59.80 million (-47.21%).
  • ANIP TTM EBITDA is now -47.21% below its all-time high of $126.66 million, reached on March 31, 2024.

Performance

ANIP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ANIP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.8%+8.4%-47.2%
3 y3 years+1925.7%+1123.1%+544.6%
5 y5 years+3.9%+1343.2%+53.0%

ANIP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-40.8%+1925.7%at high+460.4%-47.2%+544.6%
5 y5-year-40.8%+1925.7%at high+460.4%-47.2%+544.6%
alltimeall time-40.8%+224.3%at high+295.0%-47.2%+216.1%

ANIP EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$48.36M(+225.6%)
$66.86M(+5.9%)
Dec 2024
$63.12M(-40.8%)
$14.85M(-210.7%)
$63.12M(-10.0%)
Sep 2024
-
-$13.42M(-178.6%)
$70.16M(-39.9%)
Jun 2024
-
$17.07M(-61.8%)
$116.69M(-7.9%)
Mar 2024
-
$44.62M(+103.9%)
$126.66M(+18.8%)
Dec 2023
$106.60M(+325.7%)
$21.89M(-33.9%)
$106.60M(+4.4%)
Sep 2023
-
$33.12M(+22.5%)
$102.07M(+28.6%)
Jun 2023
-
$27.04M(+10.1%)
$79.34M(+46.0%)
Mar 2023
-
$24.56M(+41.6%)
$54.33M(+117.0%)
Dec 2022
$25.04M(+703.6%)
$17.35M(+67.0%)
$25.04M(-596.9%)
Sep 2022
-
$10.39M(+413.2%)
-$5.04M(-42.2%)
Jun 2022
-
$2.02M(-142.8%)
-$8.72M(-42.0%)
Mar 2022
-
-$4.73M(-62.9%)
-$15.04M(-582.6%)
Dec 2021
$3.12M(-88.9%)
-$12.73M(-289.6%)
$3.12M(-88.4%)
Sep 2021
-
$6.71M(-256.3%)
$26.92M(-21.1%)
Jun 2021
-
-$4.30M(-132.0%)
$34.13M(-10.7%)
Mar 2021
-
$13.43M(+21.3%)
$38.20M(+35.8%)
Dec 2020
$28.13M(-53.7%)
$11.07M(-20.5%)
$28.13M(+28.8%)
Sep 2020
-
$13.93M(-6291.6%)
$21.84M(-11.5%)
Jun 2020
-
-$225.00K(-106.7%)
$24.68M(-43.5%)
Mar 2020
-
$3.35M(-29.9%)
$43.71M(-28.0%)
Dec 2019
$60.73M(-11.4%)
$4.78M(-71.5%)
$60.73M(-19.7%)
Sep 2019
-
$16.77M(-10.9%)
$75.61M(-2.5%)
Jun 2019
-
$18.81M(-7.7%)
$77.52M(+4.4%)
Mar 2019
-
$20.38M(+3.7%)
$74.25M(+8.3%)
Dec 2018
$68.55M(+21.7%)
$19.65M(+5.2%)
$68.55M(+8.3%)
Sep 2018
-
$18.68M(+20.2%)
$63.30M(+3.5%)
Jun 2018
-
$15.55M(+6.0%)
$61.14M(+2.5%)
Mar 2018
-
$14.67M(+1.9%)
$59.67M(+6.0%)
Dec 2017
$56.31M(+33.0%)
$14.40M(-12.9%)
$56.31M(+15.0%)
Sep 2017
-
$16.52M(+17.4%)
$48.98M(+5.7%)
Jun 2017
-
$14.08M(+24.4%)
$46.32M(+6.8%)
Mar 2017
-
$11.31M(+60.1%)
$43.38M(+2.4%)
Dec 2016
$42.35M(+6.8%)
$7.07M(-49.0%)
$42.35M(-3.0%)
Sep 2016
-
$13.87M(+24.5%)
$43.66M(+8.4%)
Jun 2016
-
$11.14M(+8.4%)
$40.27M(+3.4%)
Mar 2016
-
$10.28M(+22.6%)
$38.96M(-1.7%)
Dec 2015
$39.64M(+64.9%)
$8.38M(-20.0%)
$39.64M(-8.8%)
Sep 2015
-
$10.47M(+6.5%)
$43.48M(+2.6%)
Jun 2015
-
$9.83M(-10.3%)
$42.39M(+37.6%)
Mar 2015
-
$10.96M(-10.3%)
$30.81M(+28.0%)
Dec 2014
$24.04M(+1311.9%)
$12.21M(+30.1%)
$24.07M(+55.8%)
Sep 2014
-
$9.39M(-635.1%)
$15.45M(+112.9%)
Jun 2014
-
-$1.75M(-141.5%)
$7.26M(+34.8%)
Mar 2014
-
$4.23M(+17.7%)
$5.38M(-695.7%)
Dec 2013
$1.70M(-106.3%)
$3.59M(+201.3%)
-$903.60K(-89.0%)
Sep 2013
-
$1.19M(-132.9%)
-$8.25M(-47.1%)
Jun 2013
-
-$3.63M(+76.2%)
-$15.59M(-18.8%)
Mar 2013
-
-$2.06M(-45.1%)
-$19.20M(-29.5%)
Dec 2012
-$27.23M
-$3.75M(-39.0%)
-$27.25M(-9.0%)
Sep 2012
-
-$6.15M(-15.0%)
-$29.95M(-17.5%)
Jun 2012
-
-$7.24M(-28.4%)
-$36.33M(-13.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$10.11M(+56.7%)
-$42.11M(-14.1%)
Dec 2011
-$50.78M(+12.0%)
-$6.45M(-48.5%)
-$49.04M(-14.9%)
Sep 2011
-
-$12.53M(-3.8%)
-$57.62M(+2.4%)
Jun 2011
-
-$13.02M(-23.6%)
-$56.29M(+5.3%)
Mar 2011
-
-$17.04M(+13.4%)
-$53.46M(+17.9%)
Dec 2010
-$45.34M(+18.4%)
-$15.03M(+34.2%)
-$45.34M(-17.7%)
Sep 2010
-
-$11.20M(+9.8%)
-$55.11M(+13.0%)
Jun 2010
-
-$10.20M(+14.4%)
-$48.78M(+13.0%)
Mar 2010
-
-$8.91M(-64.1%)
-$43.17M(+12.7%)
Dec 2009
-$38.29M(+113.1%)
-$24.80M(+409.6%)
-$38.29M(+149.6%)
Sep 2009
-
-$4.87M(+6.1%)
-$15.34M(-10.6%)
Jun 2009
-
-$4.59M(+13.7%)
-$17.15M(-5.1%)
Mar 2009
-
-$4.03M(+118.0%)
-$18.06M(+0.4%)
Dec 2008
-$17.97M(+109.2%)
-$1.85M(-72.3%)
-$17.99M(-0.8%)
Sep 2008
-
-$6.68M(+21.4%)
-$18.14M(+33.5%)
Jun 2008
-
-$5.50M(+39.0%)
-$13.59M(+27.1%)
Mar 2008
-
-$3.96M(+97.6%)
-$10.69M(+24.5%)
Dec 2007
-$8.59M(-341.5%)
-$2.00M(-5.9%)
-$8.59M(-354.7%)
Sep 2007
-
-$2.13M(-18.2%)
$3.37M(-27.7%)
Jun 2007
-
-$2.60M(+40.2%)
$4.66M(-6.7%)
Mar 2007
-
-$1.86M(-118.6%)
$5.00M(+40.5%)
Dec 2006
$3.56M(-138.7%)
$9.96M(-1290.2%)
$3.56M(-143.5%)
Sep 2006
-
-$836.80K(-63.1%)
-$8.17M(-11.8%)
Jun 2006
-
-$2.27M(-31.2%)
-$9.27M(-4.0%)
Mar 2006
-
-$3.30M(+86.5%)
-$9.65M(+4.9%)
Dec 2005
-$9.20M(-24.4%)
-$1.77M(-8.5%)
-$9.20M(-20.8%)
Sep 2005
-
-$1.93M(-27.3%)
-$11.62M(-7.9%)
Jun 2005
-
-$2.66M(-6.5%)
-$12.61M(+0.4%)
Mar 2005
-
-$2.84M(-32.0%)
-$12.56M(+3.2%)
Dec 2004
-$12.16M(+104.3%)
-$4.18M(+42.9%)
-$12.16M(+25.3%)
Sep 2004
-
-$2.93M(+12.4%)
-$9.70M(+18.5%)
Jun 2004
-
-$2.60M(+6.3%)
-$8.19M(+13.9%)
Mar 2004
-
-$2.45M(+42.1%)
-$7.19M(+20.6%)
Dec 2003
-$5.95M(+60.1%)
-$1.72M(+21.7%)
-$5.96M(+28.9%)
Sep 2003
-
-$1.42M(-11.7%)
-$4.63M(+16.0%)
Jun 2003
-
-$1.60M(+31.4%)
-$3.99M(+3.2%)
Mar 2003
-
-$1.22M(+214.8%)
-$3.87M(+3.8%)
Dec 2002
-$3.72M(+39.0%)
-$387.90K(-50.1%)
-$3.73M(-21.7%)
Sep 2002
-
-$777.80K(-47.4%)
-$4.76M(+29.6%)
Jun 2002
-
-$1.48M(+36.9%)
-$3.67M(+21.7%)
Mar 2002
-
-$1.08M(-23.8%)
-$3.02M(+14.9%)
Dec 2001
-$2.68M(-19.3%)
-$1.42M(-560.6%)
-$2.62M(+38.0%)
Sep 2001
-
$307.80K(-137.3%)
-$1.90M(-33.6%)
Jun 2001
-
-$825.40K(+19.8%)
-$2.87M(-16.9%)
Mar 2001
-
-$689.00K(-0.9%)
-$3.45M(+6.0%)
Dec 2000
-$3.31M(+118.9%)
-$695.00K(+6.0%)
-$3.25M(+27.2%)
Sep 2000
-
-$655.80K(-53.5%)
-$2.56M(+34.5%)
Jun 2000
-
-$1.41M(+186.4%)
-$1.90M(+139.2%)
Mar 2000
-
-$492.30K(+62.5%)
-$795.30K(+162.5%)
Dec 1999
-$1.51M(-39.9%)
-
-
Jun 1999
-
-$303.00K
-$303.00K
Dec 1998
-$2.52M
-
-

FAQ

  • What is ANI Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual EBITDA year-on-year change?
  • What is ANI Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is ANI Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM EBITDA year-on-year change?

What is ANI Pharmaceuticals annual EBITDA?

The current annual EBITDA of ANIP is $63.12M

What is the all time high annual EBITDA for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual EBITDA is $106.60M

What is ANI Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, ANIP annual EBITDA has changed by -$43.48M (-40.79%)

What is ANI Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of ANIP is $48.36M

What is the all time high quarterly EBITDA for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly EBITDA is $48.36M

What is ANI Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, ANIP quarterly EBITDA has changed by +$3.74M (+8.38%)

What is ANI Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of ANIP is $66.86M

What is the all time high TTM EBITDA for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM EBITDA is $126.66M

What is ANI Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, ANIP TTM EBITDA has changed by -$59.80M (-47.21%)
On this page